Talon Private Wealth
UTHR icon

Talon Private Wealth’s United Therapeutics UTHR Stock Holding History

Talon Private Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66M Buy
6,753
+1,630
+32% +$918K 0.43% 54
2026
Q1 		$3.04M Buy
+5,123
New +$2.55M 0.4% 49
2025
Q2 		$1.73M Buy
6,034
+288
+5% +$86.1K 0.24% 78
2025
Q1 		$1.79M Buy
5,746
+5,649
+5,824% +$1.94M 0.24% 73
2024
Q4 		$34.2K Buy
+97
New +$35.7K 0.01% 171

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Talon Private Wealth's UTHR Position: Q2 2026 in Review

Talon Private Wealth increased its United Therapeutics (UTHR) stake by 32% in Q2 2026, buying an estimated $918K and bringing the position to 6,753 shares worth $3.66M. The position accounts for 0.43% of the portfolio, ranked #54.

Talon Private Wealth first reported a position in UTHR in Q4 2024 and has held it in 5 quarters since. 885 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Talon Private Wealth held 6,753 shares of United Therapeutics worth $3.66M as of Q2 2026.
  • Talon Private Wealth bought 1,630 United Therapeutics shares in Q2 2026, an estimated $918K.
  • United Therapeutics made up 0.43% of Talon Private Wealth's portfolio in Q2 2026, its #54 holding.
  • Talon Private Wealth first reported a position in United Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 885 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Talon Private Wealth's 13F filing for Q2 2026, filed 11 Sep 2026.